The Asia Pacific Ocular Implants Market size is expected to grow at a healthy CAGR between 2022 and 2027.
Ocular implants are used to treat diseases and problems of the eyes. In the future years, increased investment in the research and development of newer goods will directly impact market growth. The developments in ophthalmic diagnostic technologies have resulted in a greater acceptance of the products. The ease with which online tools have educated the public about various treatment alternatives will increase the market's growth. The increasing usage of innovative ocular technologies such as artificial eyes devices has created an excellent opportunity for market players. The growing number of ocular device regulatory clearances will aid leading businesses in generating significant ocular implants market revenue.
Patients can be advised to develop timely eye care if they are aware of prevalent eye disorders and treatments. This can assist in reducing the burden of visual impairment. In addition, the incidence of diabetes and obesity is on the rise, leading to an increase in the number of persons with vision impairment. Therefore, governments are implementing various health education programs to raise knowledge about preventing these diseases and the available treatments. VISION 2020: The Right to Sight, for example, was founded in 1999 to lower the global burden of preventable blindness, particularly in emerging nations like India.
The APAC ocular implants market is further expected to grow due to increased public awareness and government initiatives for vision care management. Other advancements include advanced corneal implants that address difficulties with currently implanted devices. In addition, the ocular prosthesis provides a facial aesthetic appeal to persons who have damaged their eyes. There are several types of glass, plastic, and scleral shell implantable ocular prostheses in the market. Furthermore, the expanding trend of using cryolite glass for ocular prosthetics boosts the market for ocular implants.
The difficulty of implantation and post-implantation and the harmful effects of ocular implants may prove to be a substantial impediment to market growth. Lower treatment rates and accessibility of such devices in this nation are two main challenges impeding market expansion. Furthermore, the lengthy regulatory approval process inhibits the timely launch of new products on the market. In addition, recent ocular implant product recalls may make it more difficult for the general public to accept these devices.
This research report on the APAC Ocular Implants Market has been segmented and sub-segmented based on the following categories:
By Implant Type:
By Application:
By End User:
By Country:
Geographically, the Asian market is predicted to grow quickly because of an increase in the diabetes population and higher government healthcare spending. In addition, because the number of reported cases of blindness is increasing, cataract operations are becoming more common, and individual and government expenditure on eye care is increasing; developing countries like China and Japan are projected to be the fastest-growing in Asia Pacific region. Increasing accessibility of intraocular lens and glaucoma devices and increased awareness of ocular illnesses are two major factors driving market expansion in the region.
KEY MARKET PLAYERS:
Companies that dominate the ocular implants market in the APAC region profiled in this report are Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR Surgical.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Implant type
5.1.1 Introduction
5.1.2 Intraocular lenses
5.1.3 Corneal implants
5.1.4 Glaucoma implants
5.1.5 Orbital implants
5.1.6 Ocular prosthesis
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By implant type
5.1.9 Market Attractiveness Analysis, By implant type
5.1.10 Market Share Analysis, By implant type
5.2 application
5.2.1 Introduction
5.2.2 Glaucoma surgery
5.2.3 Oculoplasty
5.2.4 Drug delivery
5.2.5 Age related macular degeneration
5.2.6 Aesthetic purpose
5.2.7 Others
5.2.8 Y-o-Y Growth Analysis, By application
5.2.9 Market Attractiveness Analysis, By application
5.2.10 Market Share Analysis, By application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Specialty eye clinics
5.3.4 Eye institutes
5.3.5 Y-o-Y Growth Analysis, By end user
5.3.6 Market Attractiveness Analysis, By end user
5.3.7 Market Share Analysis, By end user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Implant type
6.1.3.3 By application
6.1.3.4 By end user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By implant
6.1.4.3 By application
6.1.4.4 By end user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By implant
6.1.5.3 By application
6.1.5.4 By end user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson Services, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Alcon
8.3 Bausch & Lomb Incorporated
8.4 Pfizer Inc.
8.5 STAAR SURGICAL
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.